New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2014
10:55 EDTCVU, CVU, LMNR, LMNR, PVG, PVG, RDCM, RDCM, UPI, UPI, HL, HL, PLM, PLM, MDGN, MDGN, IDSY, IDSY, DRIO, DRIO, ADEP, ADEPRoth Capital to hold a conference
26th Annual Growth Stock Conference is being held in Dana Point, California on March 9-12 with webcasted company presentations to begin on March 11 at 11 am; not all company presentations may be webcasted. Webcast Link
News For CVU;DRIO;IDSY;MDGN;PLM;HL;UPI;RDCM;PVG;LMNR;ADEP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 23, 2014
16:14 EDTUPIUroplasty sees FY15 revenue growth 9%-12%
Subscribe for More Information
16:13 EDTUPIUroplasty reports Q2 EPS (5c), consensus (7c)
Subscribe for More Information
October 22, 2014
10:09 EDTHLOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:28 EDTHLHecla Mining downgraded to Underperform from Market Perform at BMO Capital
BMO Capital downgraded Hecla to Underperform based on commodity price pressures, high capital requirements, and rich valuation. Price target lowered to $2 from $3.50.
05:45 EDTPVGPretium reports more high-grade mineralization at Valley of the Kings
Subscribe for More Information
October 20, 2014
08:03 EDTHLHecla Mining sees Q3 silver production 2.9M ounces
Subscribe for More Information
October 15, 2014
10:02 EDTHLOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:43 EDTHLHecla Mining downgraded to Underperform from Neutral at BofA/Merrill
Subscribe for More Information
08:10 EDTMDGNMedgenics reports Q3 EPS (21c) vs. (33c) last year
Gross research and development expenses for the three months ended September 30 decreased to $2.28M from $2.45M for same period in 2013. This decrease was due mainly to a decrease in subcontractor costs. Net R&D expenses for the three months ended September 30 decreased to $1.57M from $2.34M for the same period in 2013. The decrease in net R&D expenses was due to an increase of $0.61M in the participation by the Israeli Office of the Chief Scientist in addition to the decrease in gross R&D expenses. General and administrative expenses for the three months ended September 30 were $2.31M, decreasing from $2.56M for the same period in 2013 primarily due to a decrease in professional fees.
08:08 EDTMDGNMedgenics reports positive initial clinical data of MDGN-201
Subscribe for More Information
October 14, 2014
06:58 EDTMDGNMedgenics to host conference call
Subscribe for More Information
06:02 EDTHLHecla Mining management to meet with BB&T
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use